Proventix Secures Strategic Growth Funding


Proventix Systems, Inc. announces that through working with Founders Investment Banking, LLC, it has completed a growth capital funding round with a strategic investor. Headquartered in Birmingham, Ala., Proventix delivers a multimodal solution to the healthcare industry that improves caregiver hand hygiene compliance and reduces instances of healthcare-associated infections (HAIs) among patients. Utilizing RFID technology, Proventix leads with a data-centric approach which delivers valuable data, compelling clinical results, and broad operational benefits to clients.  Recognized as a pioneer and industry leader in the growing infection control space, Proventix plans to use this investment to execute on the company's aggressive growth plans and to support both domestic and international distribution agreements.

"By implementing a data-driven approach with role-based analytics and individualized feedback, our team has been able to successfully address the keystone event tied to HAIs as well as generate sustainable results for clients," says Harvey Nix, founder and CEO of Proventix. "Education is critical to improving hand hygiene compliance, and our strategy has been to influence the clinical culture through positive reinforcement and actionable intelligence. This method secures support at all levels of the organization and also produces a clear and measureable ROI from a financial and human capital standpoint. This capital, coupled with a value-added partner, will allow us to expedite several growth initiatives as well as formalize key partnerships that will broaden Proventix's reach."

Zane Tarence, managing director of Founders' Technology Practice says, "Our team was especially impressed with the technology foundation and differentiated strategy that Proventix employed.  Harvey and his team's leadership position in the infection control space give them an advantage over competitors who have only a handful of implementations and devote minimal time to understanding long-term clinical sustainability.  With a continued shift towards outcome-based funding, hospitals are highly incentivized to address HAIs, and Proventix is well positioned to meet this highly personal and growing need.  The company has a unique opportunity to meaningfully impact how care is delivered, and the Founders team is excited to watch Harvey and the Proventix team execute on this strategy."

Source: Proventix Systems, Inc.; Founders Investment Banking, LLC

Related Videos
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Lucy S. Witt, MD, investigates hospital bed's role in C difficile transmission, emphasizing room interactions and infection prevention
Chikungunya virus, 3D illustration. Emerging mosquito-borne RNA virus from Togaviridae family that can cause outbreaks of a debilitating arthritis-like disease   (Adobe Stock 126688070 by Dr Microbe)
Ambassador Deborah Birx, , speaks with Infection Control Today about masks in schools and the newest variant.
Woman lying in hospital bed (Adobe Stock, unknown)
Deborah Birx, MD
Centers for Disease Control and Prevention  (Adobe Stock, unknown)
CDC (Adobe Stock, unknown)
Inside Track with Infection Control Today
Related Content